OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of orforglipron in type 2 diabetes mellitus and obesity: a GRADE-assessed meta-analysis and trial sequential analysis with subgroup evaluations by diabetic status, obesity status, and dose regimens

HTML

Year: 2026
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Acta Diabetologica
DOI: 10.1007/s00592-025-02635-8
Authors: Asad Jamal, Suleman Khan, Maria Qadri, Asim Shah, Hammad Iftikhar, Eman Fatima, Maaz Ahmad, Munazza Sikandar, Inshal Jawed, Muhammad Muneeb, Muneeb Shad Mohmand, Zaryab Bacha, Bilal Wazir Khan, Tariq Jamal, Aizaz Anwar Khalid, Muhammad Imad Khan, Muhammad Zulkaif
Institutions: Khyber Medical College, Jinnah Sindh Medical University, Allama Iqbal Medical College, Bacha Khan Medical College, Dow University of Health Sciences, National Institute of Health, Medical University of Sofia
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: orforglipron, GLP-1 receptor agonists, type 2 diabetes, obesity, HbA1c, weight loss, systolic blood pressure, dose-response relationship, subgroup analysis, trial sequential analysis, GRADE certainty, drug safety, adverse events, glycemic control, blood pressure reduction, required information size
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7119076038
FWCI: 2.036
Cites: 33
Cited by: 3
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security